DK23891D0 - 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser - Google Patents

3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser

Info

Publication number
DK23891D0
DK23891D0 DK023891A DK23891A DK23891D0 DK 23891 D0 DK23891 D0 DK 23891D0 DK 023891 A DK023891 A DK 023891A DK 23891 A DK23891 A DK 23891A DK 23891 D0 DK23891 D0 DK 23891D0
Authority
DK
Denmark
Prior art keywords
compounds
substituted
pct
imin
triazol
Prior art date
Application number
DK023891A
Other languages
Danish (da)
English (en)
Inventor
Gunnar Leo Karup
Herbert Fritz Preikschat
Tim Niss Corell
Bodil Gyllembourg Lissau
Finn Priess Clausen
Soeren Bols Petersen
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Priority to DK023891A priority Critical patent/DK23891D0/da
Publication of DK23891D0 publication Critical patent/DK23891D0/da
Priority to IE920436A priority patent/IE66384B1/en
Priority to AT92905173T priority patent/ATE111455T1/de
Priority to HU9302323A priority patent/HUT68643A/hu
Priority to SK789-93A priority patent/SK78993A3/sk
Priority to DE69200412T priority patent/DE69200412T2/de
Priority to US08/090,012 priority patent/US5405857A/en
Priority to ES92905173T priority patent/ES2062891T3/es
Priority to PCT/DK1992/000043 priority patent/WO1992013847A1/en
Priority to CS931639A priority patent/CZ163993A3/cs
Priority to KR1019930702384A priority patent/KR930703276A/ko
Priority to BR9205624A priority patent/BR9205624A/pt
Priority to DK92905173.8T priority patent/DK0571485T3/da
Priority to RO93-01112A priority patent/RO111190B1/ro
Priority to CA002100160A priority patent/CA2100160A1/en
Priority to PL92300304A priority patent/PL169685B1/pl
Priority to EP92905173A priority patent/EP0571485B1/en
Priority to YU14292A priority patent/YU14292A/sh
Priority to PT100121A priority patent/PT100121A/pt
Priority to SI9210142A priority patent/SI9210142A/sl
Priority to JP4071309A priority patent/JPH05286950A/ja
Priority to LTIP298A priority patent/LT3184B/lt
Priority to BG97988A priority patent/BG97988A/bg
Priority to NO93932822A priority patent/NO932822L/no
Priority to FI933543A priority patent/FI933543A0/fi
Priority to EE9400082A priority patent/EE9400082A/xx
Priority to LVP-94-263A priority patent/LV10617B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK023891A 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser DK23891D0 (da)

Priority Applications (27)

Application Number Priority Date Filing Date Title
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
IE920436A IE66384B1 (en) 1991-02-12 1992-02-10 3-substituted 1,2,3,4-oxytriazole-5-imine compounds a process for the preparation thereof and a pharmaceutical preparation containing said compounds
EP92905173A EP0571485B1 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
DK92905173.8T DK0571485T3 (da) 1991-02-12 1992-02-11 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser
PL92300304A PL169685B1 (pl) 1991-02-12 1992-02-11 Sposób wytwarzania nowych 3-podstawionych zwiazków 1,2,3,4-oksa-triazolo-5-iminowych PL PL PL PL PL
SK789-93A SK78993A3 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
DE69200412T DE69200412T2 (de) 1991-02-12 1992-02-11 3-substituierte 1,2,3,4-oxatriazol-5-iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.
US08/090,012 US5405857A (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4,-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
ES92905173T ES2062891T3 (es) 1991-02-12 1992-02-11 Compuestos de 1,2,3,4-oxatriazol-5-imina 3-sustituidos, un proceso para la preparacion de los mismos y un preparado farmaceutico que contiene tales compuestos.
PCT/DK1992/000043 WO1992013847A1 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
CS931639A CZ163993A3 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazol-5-imine compounds, process of their preparation and a pharmaceutical preparation in which such compounds are comprised
KR1019930702384A KR930703276A (ko) 1991-02-12 1992-02-11 3-치환된 1,2,3,4-옥사트리아졸-5-이민 화합물, 이들의 제조 방법 및 이 화합물들을 함유하는 약학적 제제
BR9205624A BR9205624A (pt) 1991-02-12 1992-02-11 Compostos de 1,2,3,4-oxatriazol-5-imina substituída na posição 3, processo para a preparação dos mesmos e preparação farmacêutica contendo esses compostos.
AT92905173T ATE111455T1 (de) 1991-02-12 1992-02-11 3-substituierte 1,2,3,4-oxatriazol-5- iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.
RO93-01112A RO111190B1 (ro) 1991-02-12 1992-02-11 Derivati 1,2,3,4-oxatriazol-5-imino-3-substituiti si procedee de preparare a acestora
CA002100160A CA2100160A1 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
HU9302323A HUT68643A (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
SI9210142A SI9210142A (en) 1991-02-12 1992-02-12 3-substituted 1,2,3,4-oxitriazole-5-imin compounds, procedure for their preparation and preparations comprising them
YU14292A YU14292A (sh) 1991-02-12 1992-02-12 3-supstituisana 1,2,3,4-oksatriazol-5 iminska jedinjenja i postupak za njihovo dobijanje
PT100121A PT100121A (pt) 1991-02-12 1992-02-12 Compostos 1,2,3,4-oxatriazol-5-imina substituidas na posicao 3, seu processo de preparacao e preparados farmaceuticos compreendendo os referidos compostos
JP4071309A JPH05286950A (ja) 1991-02-12 1992-03-27 ３−置換１，２，３，４−オキサトリアゾール−５−イミン化合物およびその製造方法
LTIP298A LT3184B (en) 1991-02-12 1993-01-27 3-substituted 1,2,3,4-oxatriazole-5-imine compounds,a process for the preparation thereof and a pharmaceutical preparation containing said compounds
BG97988A BG97988A (bg) 1991-02-12 1993-07-27 Съединения на 3-заместени 1,2,3,4-оксатриазол-5-имин, метод за получаването им и лекарствена форма, съдържаща тези съединения
NO93932822A NO932822L (no) 1991-02-12 1993-08-09 3-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, enfremgangsmaate for fremstilling derav og et farmasoeytisk preparat inneholdende angitte forbindelser
FI933543A FI933543A0 (fi) 1991-02-12 1993-08-11 3-substituerade 1,2,3,4-oxatriatzol-5-iminfoereningar och en metod att framstaella dem och ett farmaceutiskt preparat, som innehaoller naemnda foereningar
EE9400082A EE9400082A (et) 1991-02-12 1994-08-09 3- asendatud 1, 2, 3, 4- oksatriasool- 5- imiinühendid, nende saamise meetod ja nimetatud ühendeid sisaldav farmatseutiline preparaat
LVP-94-263A LV10617B (en) 1991-02-12 1994-12-23 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical praparation containing said compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
JP4071309A JPH05286950A (ja) 1991-02-12 1992-03-27 ３−置換１，２，３，４−オキサトリアゾール−５−イミン化合物およびその製造方法

Publications (1)

Publication Number Publication Date
DK23891D0 true DK23891D0 (da) 1991-02-12

Family

ID=26063591

Family Applications (2)

Application Number Title Priority Date Filing Date
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
DK92905173.8T DK0571485T3 (da) 1991-02-12 1992-02-11 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92905173.8T DK0571485T3 (da) 1991-02-12 1992-02-11 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser

Country Status (23)

Country Link
US (1) US5405857A (pt)
EP (1) EP0571485B1 (pt)
JP (1) JPH05286950A (pt)
AT (1) ATE111455T1 (pt)
BG (1) BG97988A (pt)
BR (1) BR9205624A (pt)
CA (1) CA2100160A1 (pt)
CZ (1) CZ163993A3 (pt)
DE (1) DE69200412T2 (pt)
DK (2) DK23891D0 (pt)
ES (1) ES2062891T3 (pt)
FI (1) FI933543A0 (pt)
HU (1) HUT68643A (pt)
IE (1) IE66384B1 (pt)
LT (1) LT3184B (pt)
LV (1) LV10617B (pt)
NO (1) NO932822L (pt)
PL (1) PL169685B1 (pt)
PT (1) PT100121A (pt)
RO (1) RO111190B1 (pt)
SI (1) SI9210142A (pt)
SK (1) SK78993A3 (pt)
WO (1) WO1992013847A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321109C2 (de) * 1993-06-25 1998-01-29 Sanol Arznei Schwarz Gmbh Pharmakologisch aktive Verbindungen mit Nitrosohydrazinpartialstruktur
WO1996011191A1 (en) * 1994-10-07 1996-04-18 A/S Gea Farmaceutisk Fabrik Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis
US8470417B2 (en) 2004-04-02 2013-06-25 Curwood, Inc. Packaging inserts with myoglobin blooming agents, packages and methods for packaging
US8741402B2 (en) * 2004-04-02 2014-06-03 Curwood, Inc. Webs with synergists that promote or preserve the desirable color of meat
US8545950B2 (en) * 2004-04-02 2013-10-01 Curwood, Inc. Method for distributing a myoglobin-containing food product
US8110259B2 (en) 2004-04-02 2012-02-07 Curwood, Inc. Packaging articles, films and methods that promote or preserve the desirable color of meat
US8053047B2 (en) 2004-04-02 2011-11-08 Curwood, Inc. Packaging method that causes and maintains the preferred red color of fresh meat
US8029893B2 (en) 2004-04-02 2011-10-04 Curwood, Inc. Myoglobin blooming agent, films, packages and methods for packaging
US7867531B2 (en) 2005-04-04 2011-01-11 Curwood, Inc. Myoglobin blooming agent containing shrink films, packages and methods for packaging
US8653080B2 (en) * 2009-01-14 2014-02-18 Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2015878B (en) * 1978-03-10 1982-05-26 Shell Int Research Biocidal compositions
US4239355A (en) 1979-02-05 1980-12-16 Vought Corporation Visual simulator projection system
US4329355A (en) * 1979-03-01 1982-05-11 Henry David W Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
JP2708500B2 (ja) 1988-09-27 1998-02-04 三菱電機株式会社 積層形燃料電池
JP2905041B2 (ja) * 1993-07-02 1999-06-14 三菱電機株式会社 メッセージ送受信装置
JPH0720904A (ja) * 1993-07-05 1995-01-24 Toshiba Corp プロセス制御装置のリミッタ設定装置
JP2009102700A (ja) 2007-10-24 2009-05-14 Sumitomo Kinzoku Kozan Siporex Kk 軽量気泡コンクリート補強鉄筋用防錆剤

Also Published As

Publication number Publication date
EP0571485A1 (en) 1993-12-01
BR9205624A (pt) 1994-11-08
ES2062891T3 (es) 1994-12-16
DE69200412D1 (de) 1994-10-20
PT100121A (pt) 1993-05-31
CZ163993A3 (en) 1994-01-19
FI933543A (fi) 1993-08-11
FI933543A0 (fi) 1993-08-11
IE66384B1 (en) 1995-12-27
SK78993A3 (en) 1994-03-09
JPH05286950A (ja) 1993-11-02
SI9210142A (en) 1995-08-31
LV10617B (en) 1995-12-20
RO111190B1 (ro) 1996-07-30
ATE111455T1 (de) 1994-09-15
DE69200412T2 (de) 1995-02-16
CA2100160A1 (en) 1992-08-13
EP0571485B1 (en) 1994-09-14
WO1992013847A1 (en) 1992-08-20
HUT68643A (en) 1995-07-28
LT3184B (en) 1995-03-27
PL169685B1 (pl) 1996-08-30
IE920436A1 (en) 1992-08-12
BG97988A (bg) 1994-06-30
NO932822D0 (no) 1993-08-09
LV10617A (lv) 1995-04-20
DK0571485T3 (da) 1994-10-17
US5405857A (en) 1995-04-11
NO932822L (no) 1993-08-09
LTIP298A (en) 1994-08-25
HU9302323D0 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
EE200000318A (et) Uudsed ühendid
NL970045I2 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
DK165199C (da) Aktivatorpraeparat, fremgangsmaade til kvantitativ bestemmelse af protein c under anvendelse af praeparatet, antithrombotisk laegemiddel indeholdende praeparatet og fremgangsmaade til udvinding af aktiveret protein c under anvendelse af praeparatet
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
NO178768C (no) 11-aryl-4-östrener og antikonsepsjonsmidler inneholdende disse
DK23891D0 (da) 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
NO972449L (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
DK218189D0 (da) Fumarsyrekonjugat og farmaceutisk praeparat indeholdende en saadan forbindelse
DK418986A (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
DK493988D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
DE3874606D1 (de) Behandlung von viraler infektion.
NO883219D0 (no) Framgangsmaate for framstilling av beta-lactam-forbindelse, mellomprodukt for framstilling av denne, og medisinske sammensetninger for behandling av bakteriologiske infeksjonssykdommer inneholdende denne.
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
NO883674D0 (no) 5-hydroksy-3-aminokroman-forbindelser, fremgangsmaater for deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelsene og metoder for behandling dermed.
NO883285L (no) Fremgangsmaate til fremstilling av leukotrienantagonister.
MC2013A1 (fr) Methode pour la detection des anticorps diriges contre le virus d'immunodeficience humaine
DK342287D0 (da) Protein med prokoagulerende virkning,fremgangsmaade til fremstilling af et saadant protein og farmaceutisk praeparat indeholdende proteinet

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment